Robin Gellerman
Robin Gellerman is the Product Marketing Manager for Life Sciences Enterprise Content Management solutions at OpenText. With over 20 years in the enterprise content management industry, Robin has held a variety of product and industry marketing positions supporting document management, capture and customer communications technologies at OpenText, the Enterprise Content Division of EMC, Captiva and Document Sciences. Most recently, Robin was the Industry Strategist for retail, and has previously worked with energy & engineering and healthcare solutions.Top information management trends for life sciences in 2024
The life sciences industry has seen monumental change over the past few years. From the Covid-19 pandemic to a spike in investment, coupled with rising…
Top information management trends for life sciences in 2024
The life sciences industry has seen monumental change over the past few years. From the Covid-19 pandemic to a spike in investment, coupled with rising…
Assembling the pieces: Archiving and retention in Life Sciences
In the world of pharmaceuticals, something interesting keeps happening—companies acquire, merge, or divest from other companies. It’s like a puzzle they’re trying to solve getting…
What’s new in OpenText Life Sciences solutions
Life Sciences organizations are finding new ways to work within distributed and hybrid work processes adopted during the pandemic that remains in place today. Mastering…
Introducing secure print controls for pharmaceutical manufacturers
Government agencies around the world, including the US Food and Drug Administration (FDA), use current Good Manufacturing Practices (cGMP) as the primary way to ensure…
Are you ready for IDMP 2.x?
Earlier this month OpenText customers from Americas and Europe gathered at the OpenText™ Documentum™ for Life Sciences user group and discussed Identification of Medicinal Products…
Adapt, pivot and persevere: Life Sciences in 2021
Even with 2020 in the rearview mirror, the impact of last year will linger for some time. Clinical trials moved to virtual models, supply chain…
What’s new in OpenText Life Sciences Smart View 20.4
With the shift to remote work environments, Life Sciences organizations need a way to provide their workers with secure and compliant access to highly regulated…
Introducing OpenText Content Cloud for Life Sciences
OpenText™ is thrilled to announce the launch of OpenText Content Cloud™ for Life Sciences, an innovative new offering that brings the proven productivity and governance…
What’s new in OpenText Documentum for Life Sciences Cloud Edition (CE) 20.2
Pharmaceutical and Life Sciences companies are in the public spotlight as they pursue advanced therapies and vaccines to combat the coronavirus pandemic. Productivity, flexibility and…
What’s new in Release 19.4 for OpenText Life Sciences Express
OpenText™ Life Science Express has a new name: OpenText™ Life Sciences Smart View. Learn about it here. If you work in the Life Sciences industry,…
What’s new in OpenText Documentum for Life Sciences Release 16 EP7
Every pharmaceutical company wants to accelerate the drug development process – from discovery to commercial success – to deliver new treatments that improve patient outcomes….
What’s new in OpenText Documentum for Life Sciences EP6
A lot has happened in the Life Sciences industry since the last update to OpenText™ Documentum for Life Sciences in 2018. Regulatory changes, such as…
Stay in the loop!
Get our most popular content delivered monthly to your inbox.
